Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | QPCT | Q16769 | 1/20 | 0.31 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12150031 | 0.82 | CYP26A1 (0.40) | TBXAS1KDM4EALDH1A1KMT2A | |
| SCHEMBL17512450 | 0.80 | CYP3A4 (0.40) | TBXAS1KDM4EQPCT | |
| SCHEMBL9913350 | 0.78 | TBXAS1 (0.34) | TBXAS1KDM4EALDH1A1QPCTPOLB | |
| SCHEMBL9913356 | 0.78 | TBXAS1 (0.34) | TBXAS1KDM4EALDH1A1QPCTPOLB | |
| SCHEMBL28418676 | 0.77 | TBXAS1 (0.33) | TBXAS1KDM4EALDH1A1POLB | |
| SCHEMBL8569467 | 0.75 | TBXAS1 (0.35) | TBXAS1ALDH1A1POLB | |
| SCHEMBL9913351 | 0.73 | ALDH1A1 (0.35) | TBXAS1ALDH1A1QPCT | |
| SCHEMBL20474442 | 0.73 | MAPT (0.31) | TBXAS1KDM4E | |
| SCHEMBL6808774 | 0.73 | KMT2A (0.41) | AHRALDH1A1QPCTKMT2A | |
| SCHEMBL5647599 | 0.72 | CYP2D6 (0.39) | TBXAS1KDM4EALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354404-A1 | PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354404-A1 | PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF | DNPEP, PEPD, ANPEP | AHR 2638/4885TBXAS1 698/4885KDM4E 4843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.